SAN DIEGO, CA--(Marketwired - Mar 29, 2017) - Youngevity International, Inc. (
Mike Brosnan, the CEO and President of BellaVita, is joining Youngevity as VP of Sales & Marketing, Asia. All of the BellaVita offices in Asia remain open and are now incorporated into Youngevity operations. A number of BellaVita U.S.-based employees will join the Youngevity Utah office and continue to service the Asian market.
"The BellaVita acquisition represents a true extension of our mission of betterment, our commitment to quality and our shared passion in optimal health," stated Steve Wallach, CEO and Co-Founder of Youngevity. "Furthermore, the Mediterranean diet and lifestyle ingredient basis of the product lines continues to grow in popularity across Asia and are only beginning to be fully recognized in the U.S. market -- which we expect will make this acquisition a key driver of our overall global expansion strategy."
"BellaVita understands the nuance, culture and technology of the Asian market," continues Dave Briskie, President and CFO of Youngevity. "BellaVita, whose culture mirrors Youngevity, offers us a strong synergistic partner in Asia -- with its tight-knit community of Distributors, its established customers and its loyal employees who deliver on the brand promise. This acquisition should provide a strong foothold in Asia through established offices including the countries of Taiwan, Indonesia, Malaysia, Hong Kong, and Japan."
"BellaVita's focus on Mediterranean health and Mediterranean whole food inspired products fit perfectly into the Youngevity culture and contribute to Youngevity's core offerings," stated Mike Brosnan. "We have worked with Steve and Michelle Wallach, Dave Briskie, and the Youngevity Management team -- and have been so impressed with the shared commitment to providing the highest quality products and experiences possible. I believe the combination of Bellavita and Youngevity provides a perfect fit for business growth in Asia. Youngevity's established offices in Singapore and the Philippines combined with Bellavitas market presence provides us with sales centers in 7 countries in Asia. We look forward to a promising future together with Youngevity."
Youngevity was founded upon the pioneering principles of Dr. Joel Wallach; always looking forward to the betterment of society. Today Youngevity continues to meet this mission with groundbreaking products, innovative services and a fulfilling business opportunity individually defined through flexibility and personal lifestyle choices. And in this Pursuit of Betterment, the Company continues to build and grow its Youngevity Be the Change Foundation. 100% of the profits from Youngevity Be the Change Coffee, and other special products highlighted on the Foundation website finance Foundation operations.
About Youngevity International, Inc.
Youngevity International, Inc. (
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," "encouraged" and similar expressions and include statements regarding the Mediterranean diet and lifestyle ingredient basis of the product lines continuing to grow in popularity across Asia and the acquisition being a key driver of our overall global expansion strategy, the acquisition providing a strong foothold in Asia and the belief the combination of Bellavita and Youngevity provides a perfect fit for business growth in Asia. The forward-looking statements are based on management's expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to successfully integrate Bellavita into our operations, to expand operations in particular in Asia, to continue our financial performance, and growth and the other factors described in our filings with the SEC. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.